Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Eric Jorgenson who wrote (1051)	5/19/1998 10:53:00 PM
From: Skywatcher	Read Replies (1) \| Respond to of 2135

Onyxx has a very sophisticated treatment that is way ahead in terms of time and trials compared to ENMD...They don't tout that they have the "CURE". And companies that are releasing news and talking to the press using this word are irresponsible. I don't think we have seen the last of the 20's in this stock...people investing just don't have the time to wait a few years for a whole series of trials and tests. The mice and tumors thing just doesn't hold water for a long period of time. See the ONXX chart when they got this much publicity a year or so ago. Same scenario for this stock only there is a biotech fever going on right now and it will take a little longer, but ONXX is doing well and has another year under their belt. chris